Inverse association of serum long-acting natriuretic peptide and bone mineral density in renal transplant recipients

Clinical Transplantation

Volumn 26, Issue 2, 2012, Pages

  Hsu, Bang Gee ^a,b   Ho, Guan Jin ^b   Lee, Chung Jen ^c   Yang, Ying Chin ^b   Chen, Yen Cheng ^b   Shih, Ming Hui ^b   Lee, Ming Che ^a,b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

Author keywords

Bone mineral density; Kidney transplantation; Long acting natriuretic peptide

Indexed keywords

NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME IMMUNOASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ATRIAL NATRIURETIC FACTOR; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PEPTIDE FRAGMENTS;

EID: 84859808223     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01575.x     Document Type: Article

References (27)

1. Lin JT, Lane JM. Osteoporosis: a review. Clin Orthop Relat Res 2004: 425: 126.
2. Malluche HH, Monier-Faugere MC, Herberth J. Bone disease after renal transplantation. Nat Rev Nephrol 2010: 6: 32.
3. Hamdy NA. Calcium and bone metabolism pre- and post-kidney transplantation. Endocrinol Metab Clin North Am 2007: 36: 923.
4. Ebeling PR. Approach to the patient with transplantation-related bone loss. J Clin Endocrinol Metab 2009: 94: 1483.
5. Sprague SM, Josephson MA. Bone disease after kidney transplantation. Semin Nephrol 2004: 24: 82.
6. Vesely DL. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer? Clin Exp Pharmacol Physiol 2006: 33: 169.
7. Vesely DL. Atrial natriuretic peptides: anticancer agents. J Investig Med 2005: 53: 360.
8. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006: 27: 47.
9. Hagiwara H, Inoue A, Yamaguchi A et al. cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells. Am J Physiol 1996: 270: C1311.
10. Lenz A, Bennett M, Skelton WP 4th et al. Vessel dilator and C-type natriuretic peptide enhance the proliferation of human osteoblasts. Pediatr Res 2010: 68: 405.
11. Lee MC, Lee CJ, Ho GJ et al. Hyperleptinemia positively correlated with metabolic syndrome in renal transplant recipients. Clin Transplant 2010: 24: E124.
12. Hsu BG, Chen YC, Lee RP et al. Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease. Circ J 2010: 74: 327.
13. Genant HK, Cooper C, Poor G et al. Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 1999: 10: 259.
14. Dempster DW, Lindsay R. Pathogenesis of osteoporosis. Lancet 1993: 34: 797.
15. Lane JM, Russell L, Khan SN. Osteoporosis. Clin Orthop 2000: 372: 139.
16. Falkiewicz K, Boratyńska M, Zmonarski SC et al. Evolution of bone disease at 2years after transplantation: a single-center study. Transplant Proc 2009: 41: 3063.
17. Ahmadpoor P, Reisi S, Makhdoomi K et al. Osteoporosis and related risk factors in renal transplant recipients. Transplant Proc 2009: 41: 2820.
18. Guney E, Kisakol G, Ozgen G et al. Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg 2003: 13: 383.
19. Lafleur J, Mcadam-Marx C, Kirkness C et al. Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature. Ann Pharmacother 2008: 42: 375.
20. Pirro M, Fabbriciani G, Leli C et al. High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women. J Bone Miner Metab 2010: 28: 88.
21. Dolgos S, Hartmann A, Bønsnes S et al. Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation. Clin Transplant 2008: 22: 462.
22. Bayat N, Einollahi B, Pourfarzian V et al. Bone mineral density changes within 11months of renal transplantation in Iranian patients. Transplant Proc 2007: 39: 1039.
23. Unal A, Kocyigit I, Sipahioglu MH et al. Loss of bone mineral density in renal transplantation recipients. Transplant Proc 2010: 42: 3550.
24. Ing SW, Sinnott LT, Donepudi S et al. Change in bone mineral density at one year following glucocorticoid withdrawal in kidney transplant recipients. Clin Transplant 2011: 25: E113.
25. Durieux S, Mercadal L, Orcel P et al. Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation 2002: 74: 496.
26. Mainra R, Elder G. Managing bone complications after kidney transplantation. Nephrology 2009: 14: 437.
27. Kulak CA, Borba VZ, Kulak Júnior J et al. Post-transplantation osteoporosis. Arq Bras Endocrinol Metabol 2010: 54: 143.